Latest Tocagen Inc. Stories
Industry and Academic Leader Co-Founded Several Successful Biotechnology Companies, Including Alnylam, Cubist and Alkermes SAN DIEGO, Feb.
SAN DIEGO, Dec.
Results Presented at the 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology MIAMI, Nov.
Builds Expert Independent Board As Company Advances Towards Late-Stage Brain Cancer Trials SAN DIEGO, Nov.
Names Wayne Saville, M.D., Vice President, Clinical Development, and Mary Rose Keller Vice President, Clinical Operations SAN DIEGO, Aug.
In Addition, Toca 511 Clinical Data to be Presented at American Society of Clinical Oncology Annual Meeting SAN DIEGO, May 22, 2014 /PRNewswire/ --
Results Continue to Show Safety and Promising Survival; Program to Advance into a Randomized, Controlled Trial SAN DIEGO, April 10, 2014 /PRNewswire/ --
Pharmaceutical Executive Brings Additional Expertise in Oncology Drug Development and Commercialization SAN DIEGO, March 25, 2014 /PRNewswire/ --
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.